SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-022252
Filing Date
2023-05-15
Accepted
2023-05-15 16:32:06
Documents
63
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vcnx-20230331.htm   iXBRL 10-Q 1380232
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES vcnx-ex31_1.htm EX-31.1 29734
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES vcnx-ex31_2.htm EX-31.2 29707
4 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO vcnx-ex32_1.htm EX-32.1 16620
  Complete submission text file 0000950170-23-022252.txt   5554046

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vcnx-20230331_lab.xml EX-101.LAB 393302
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vcnx-20230331_cal.xml EX-101.CAL 27987
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vcnx-20230331.xsd EX-101.SCH 48684
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vcnx-20230331_def.xml EX-101.DEF 161462
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vcnx-20230331_pre.xml EX-101.PRE 277869
57 EXTRACTED XBRL INSTANCE DOCUMENT vcnx-20230331_htm.xml XML 838566
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Filer) CIK: 0001205922 (see all company filings)

IRS No.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38624 | Film No.: 23923228
SIC: 2834 Pharmaceutical Preparations